方宪康

宪康 方 is a Senior Director of Pharmacology with extensive experience in preclinical pharmacology research, particularly in pharmacokinetics and pharmacodynamics. They previously held the role of Director of in vivo pharmacology at Structure Therapeutics and worked as a Scientist III at Eli Lilly China, where they coordinated teams to develop animal models for evaluating novel drug targets.宪康 方 earned a postdoctoral degree in Pharmacology from 复旦大学, contributing significantly to the field through leadership and collaboration on multifaceted research projects.